Skip to main content
The BMJ logoLink to The BMJ
letter
. 1995 Apr 15;310(6985):1008. doi: 10.1136/bmj.310.6985.1008a

Thrombolysis in patients with diabetes. More evidence that the treatment should not necessarily be withheld.

D K Newman, M P Snead, D W Flanagan, J D Scott
PMCID: PMC2549392  PMID: 7728007

Full text

PDF

Page 1008

1008

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Glaser B. M. The use of intravitreal thrombin to control hemorrhage during retinectomy. Retina. 1988;8(1):1–2. doi: 10.1097/00006982-198808010-00001. [DOI] [PubMed] [Google Scholar]
  2. Thompson J. T., de Bustros S., Michels R. G., Rice T. A. Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage. Arch Ophthalmol. 1987 Feb;105(2):191–195. doi: 10.1001/archopht.1987.01060020045025. [DOI] [PubMed] [Google Scholar]
  3. Ward H., Yudkin J. S. Thrombolysis in patients with diabetes. BMJ. 1995 Jan 7;310(6971):3–4. doi: 10.1136/bmj.310.6971.3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES